
New Cancer Drug Shrinks Tumors in 62% of Lung Cancer Patients
A promising new pill shrank tumors in nearly two-thirds of lung cancer patients and 40% of pancreatic cancer patients in early trials. The results exceeded expectations and could offer fresh hope for people facing these difficult diagnoses.














